Two Sigma Advisers
VIGL

Two Sigma Advisers’s Vigil Neuroscience VIGL Stock Holding History

Two Sigma Advisers’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,900
Closed -$31.9K – 2569
2025
Q1 		$31.9K Sell
17,900
-51,200
-74% -$115K ﹤0.01% 2340
2024
Q4 		$117K Buy
69,100
+49,000
+244% +$145K ﹤0.01% 2201
2024
Q3 		$68.3K Buy
+20,100
New +$74.5K ﹤0.01% 2197
2024
Q2 		– Sell
-24,100
Closed -$82.2K – 2683
2024
Q1 		$82.2K Buy
+24,100
New +$75.2K ﹤0.01% 2319

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Two Sigma Advisers's VIGL Position: Q2 2025 in Review

Two Sigma Advisers sold out of Vigil Neuroscience (VIGL) in Q2 2025, closing a stake of 17,900 shares — an estimated $31.9K sold.

Two Sigma Advisers first reported a position in VIGL in Q1 2024 and held it in 4 quarters. The position peaked at $117K in Q4 2024. 78 funds tracked by Wall St. Rank hold VIGL as of Q2 2025.

  • Two Sigma Advisers reported no remaining Vigil Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 17,900 Vigil Neuroscience shares in Q2 2025, an estimated $31.9K.
  • Two Sigma Advisers first reported a position in Vigil Neuroscience in Q1 2024 and held it in 4 quarters.
  • Two Sigma Advisers's Vigil Neuroscience position peaked at $117K in Q4 2024.
  • 78 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2025.

Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.